Today@Dal
» Go to news mainResearch study for healthy men ages 18‑44
Posted by Clinical Trials Research Center on
August 20, 2013
in
General Announcements
RSV (respiratory syncitial virus) CAN cause serious lung infections in infants, young children and the elderly The Canadian Center for Vaccinology at the IWK is studying a vaccine that may provide protection against RSV.
If you are a healthy man between the ages of 18 and 44 and are interested in taking part in this important study, please contact Cathy at 470-7015.
If eligible to take part, you will be reimbursed for travel and parking.
For more information about the study and the Canadian Center for Vaccinology, please visit our website.
Recent News
- Buy your 50/50 tickets in support of United Way
- Temporary change to LMP entrances
- Call for 2025 OpenThinkers
- New surplus items added in Halifax and Truro
- Food services survey deadline extended
- In Memoriam: Dr. Herbert Hancock
- Newest OpenThink articles now available
- Where suppliers can meet Dal Procurement